Unresectable hepatocellular carcinoma is extremely difficult to treat. TheraSphere consists
of yttrium-90 (a pure beta emitter) microspheres, which are injected into the hepatic arteries …

Background The aim of this study was to evaluate the success of selective intraarterial
radionuclide therapy (SIRT) with Yttrium-90 (Y-90) microspheres in liver metastases of …

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and
affects millions worldwide. Due to the lack of effective systemic therapies for HCC …

AIM: To evaluate the efficacy and safety of selective internal radiation therapy (SIRT).
MATERIALS AND METHODS: A retrospective analysis was undertaken of all patients who …

90Yttrium microspheres for nonresectable liver cancer: the University of Connecticut Health
Center experience. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Abstract Purpose Intra-arterial yttrium-90 (90 Y) microsphere radioembolization (RE) is an
emerging treatment option with good outcomes reported predominantly in hepatitis C …

OBJECTIVE To study the clinical results of hepatic radioembolization with Yttrium-90 (90Y)
glass microspheres in the treatment of primary liver cancer. METHODS Seventeen patients …

Transarterial radioembolization (TARE) is a form of brachytherapy in which intra-arterially
injected yttrium-90-loaded microspheres serve as a source for internal radiation purposes …

Purpose To address the feasibility of yttrium-90 (90 Y) glass microspheres administered at a
boosted dose in large hepatocellular carcinomas (HCCs). Materials and Methods From July …

Transarterial radioembolization with yttrium-90 resin microspheres (SIR-Spheres; Sirtex
Medical Limited, Sydney, Australia) is a liver-directed therapy that is gaining recognition as a …